Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

COping with acute sickle cell hemolysis

Satheesh Chonat, Sean R. Stowell

Blood (2024) 143 (24): 2452–2453.

https://doi.org/10.1182/blood.2024024710

Published: 2024

Journal Articles

Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation

Jacopo Ceolan, Katie Seu, Athina Ntoumaziou, Yasmin Elgammal, Sana Emberesh, Lisa Bilston, Donald Richards, Kathryn E. Dickerson, Satheesh Chonat, Natalia Rydz, Carolyn Lutzko, Ammar Husami, Wenying Zhang, Theodosia A. Kalfa

Blood (2023) 142 (Supplement 1): 2459.

https://doi.org/10.1182/blood-2023-189140

Published: 2023

Journal Articles

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

Marco Aurelio Salvino, Bulent Antmen, Frederick Chite Asirwa, Satheesh Chonat, Lucia De Franceschi, Perla Eleftheriou, Adlette Inati, Johnny Mahlangu, Erfan Nur, Salvador Payán-Pernía, Asad Charania, Diana Gradinaru, Allison Hsia, Yves Luder, Thomas Perretti, Sasha Srekovic, Pablo Bartolucci

Blood (2023) 142 (Supplement 1): 1158.

https://doi.org/10.1182/blood-2023-179858

Published: 2023

Journal Articles

Patients with Sickle Cell Disease Can Demonstrate a Constellation of Symptoms Associated with Hyper-Hemolysis without Recent Transfusion

Erin R. Garrett, Satheesh Chonat, Michael Briones, Margo R. Rollins

Blood (2023) 142 (Supplement 1): 5293.

https://doi.org/10.1182/blood-2023-187100

Published: 2023

Journal Articles

Age, Gvhd Prophylaxis, and Timing Matter in Thrombotic Microangiopathy after Hematopoietic Cell Therapy- a Secondary CIBMTR Analysis

Michelle L Schoettler, Benjamin Watkins, Muna Qayed, Satheesh Chonat, Adrianna Westbrook, Kirsten M Williams

Blood (2023) 142 (Supplement 1): 2153.

https://doi.org/10.1182/blood-2023-174752

Published: 2023

Journal Articles

Characterizing Pregnancy Outcomes in a Humanized Mouse Model of Sickle Cell Disease

Christopher Chambliss, Elizabeth Manci, Earl Fields, Jesse Bueno, Adeola Michael, Satheesh Chonat, David R Archer

Blood (2023) 142 (Supplement 1): 563.

https://doi.org/10.1182/blood-2023-185898

Published: 2023

Journal Articles

Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH

Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia MC Langemeijer, Satheesh Chonat, Jia Cao, Vincent Chow, Haby Henary

Blood (2023) 142 (Supplement 1): 4092.

https://doi.org/10.1182/blood-2023-186362

Published: 2023

Journal Articles

Preliminary Pharmacodynamic Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Mira Patel Pochron, Adeseye Michael Akinsete, Shehu Umar Abdullahi, Foluke A Fasola, Modupe Idowu, Sharon Pennington, William B Ershler, Marshall Patrick Stagg, Earl Fields, Morgan Sterling, Satheesh Chonat, Yuvika Paliwal, Karena Kong, David R Archer, Adeyemi Adenola, Eleanor A Lisbon

Blood (2023) 142 (Supplement 1): 1155.

https://doi.org/10.1182/blood-2023-188929

Published: 2023

Journal Articles

Acute Chest Syndrome at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Danielle Cicka, Michelle L Schoettler, Morgan L. McLemore, Fuad El Rassi, Satheesh Chonat

Blood (2023) 142 (Supplement 1): 3886.

https://doi.org/10.1182/blood-2023-191018

Published: 2023

Journal Articles

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Blood (2023) 142 (12): 1082–1098.

https://doi.org/10.1182/blood.2022018591

Published: 2023

Includes: Supplemental data

Journal Articles

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Austin Kulasekararaj, Francesco Lanza, Alexandros Arvanitakis, Saskia M.C. Langemeijer, Satheesh Chonat, Vincent Chow, Jean Pan, Yaneth Saportas, Vladimir Hanes, Haby Henary

Blood (2022) 140 (Supplement 1): 8660–8662.

https://doi.org/10.1182/blood-2022-166722

Published: 2022

Journal Articles

Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

Blood (2022) 140 (Supplement 1): 5313–5315.

https://doi.org/10.1182/blood-2022-169125

Published: 2022

Journal Articles

Complement Drives Acute Chest Syndrome in a Model of Sickle Cell Disease

Satheesh Chonat, Jayre A Jones, Seema R Patel, Patricia E Zerra, Lauren A Jeffers, Ryan Philip Jajosky, Connie M. Arthur, Michael Koval, Clinton H. Joiner, David R. Archer, Sean R. Stowell

Blood (2022) 140 (Supplement 1): 8221–8222.

https://doi.org/10.1182/blood-2022-170830

Published: 2022

Journal Articles

Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression

Ryan Philip Jajosky, Jerry W. Allen, Patricia E Zerra, Cheryl L Maier, Satheesh Chonat, Chance John Luckey, John D. Roback, Ross M. Fasano, Cassandra D. Josephson, John P Manis, Li Chai, Jeanne E. Hendrickson, Krystalyn E Hudson, Connie M. Arthur, Sean R. Stowell

Blood (2022) 140 (Supplement 1): 73–74.

https://doi.org/10.1182/blood-2022-170081

Published: 2022

Journal Articles

Addressing Clinical Management Challenges in the Treatment of Rare, Non-Malignant Hematologic Disorders through Educational Interventions

Sumera Ackbarali, Tariqa Ackbarali, Katie Kowalski, Hans C. Lee, Vaishali Sanchorawala, Shirley D'Sa, Satheesh Chonat, Carlos M. de Castro

Blood (2022) 140 (Supplement 1): 13057–13058.

https://doi.org/10.1182/blood-2022-157219

Published: 2022

Journal Articles

A virtuosic CADENZA played by sutimlimab

Satheesh Chonat, Sean R. Stowell

Blood (2022) 140 (9): 933–935.

https://doi.org/10.1182/blood.2022017284

Published: 2022

Journal Articles

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome

Blood (2022) 139 (3): 369–383.

https://doi.org/10.1182/blood.2021012924

Published: 2022

Includes: Supplemental data

Journal Articles

Complement Activation during Vaso-Occlusive Pain Crisis in Pediatric Sickle Cell Disease

Justin J Yoo, Sara H Graciaa, Jayre A Jones, Zoey Zuo, Connie M Arthur, Traci Leong, Clinton H. Joiner, Sean R Stowell, Satheesh Chonat

Blood (2021) 138 (Supplement 1): 858.

https://doi.org/10.1182/blood-2021-154132

Published: 2021

Journal Articles

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Blood (2021) 138 (Supplement 1): 848.

https://doi.org/10.1182/blood-2021-147711

Published: 2021

Journal Articles

Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice

Patricia E. Zerra, Seema R. Patel, Ryan Philip Jajosky, Connie M. Arthur, James W. McCoy, Jerry William Lynn Allen, Satheesh Chonat, Ross M. Fasano, John D. Roback, Cassandra D. Josephson, Jeanne E. Hendrickson, Sean R. Stowell

Blood (2021) 138 (8): 706–721.

https://doi.org/10.1182/blood.2020009376

Published: 2021

Includes: Supplemental data

NARROW

COping with acute sickle cell hemolysis

Erythrocyte Disorders Mimicking Congenital Dyserythropoietic Anemia Based on Bone Marrow Pathology Exposed By Genetic Evaluation

Trials in Progress: The Randomized, Double-Blind, Placebo-Controlled Phase 1b CROSSWALK-a and Phase 2a CROSSWALK-c Trials - Crovalimab for the Treatment and Prevention of Vaso-Occlusive Episodes in Sickle Cell Disease

Patients with Sickle Cell Disease Can Demonstrate a Constellation of Symptoms Associated with Hyper-Hemolysis without Recent Transfusion

Age, Gvhd Prophylaxis, and Timing Matter in Thrombotic Microangiopathy after Hematopoietic Cell Therapy- a Secondary CIBMTR Analysis

Characterizing Pregnancy Outcomes in a Humanized Mouse Model of Sickle Cell Disease

Efficacy of Parallel and Crossover Analysis As Well As Pharmacokinetic Similarity Were Confirmed between ABP 959 and Eculizumab Reference Product in Patients with PNH

Preliminary Pharmacodynamic Results from a Multicenter Phase 2/3 Study of Next-Generation HbS Polymerization Inhibitor GBT021601 for the Treatment of Patients with Sickle Cell Disease

Acute Chest Syndrome at the Emory University Georgia Comprehensive Sickle Cell Center at Grady Health System

Antibody-mediated antigen loss switches augmented immunity to antibody-mediated immunosuppression

Efficacy and Safety of Biosimilar Candidate ABP 959 As Compared with Eculizumab Reference Product in Paroxysmal Nocturnal Hemoglobinuria

Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

Complement Drives Acute Chest Syndrome in a Model of Sickle Cell Disease

Antibody-Mediated Antigen Loss Can Switch an Augmented Immune Response to Antibody-Mediated Immunosuppression

Addressing Clinical Management Challenges in the Treatment of Rare, Non-Malignant Hematologic Disorders through Educational Interventions

A virtuosic CADENZA played by sutimlimab

T-follicular helper cell expansion and chronic T-cell activation are characteristic immune anomalies in Evans syndrome

Complement Activation during Vaso-Occlusive Pain Crisis in Pediatric Sickle Cell Disease

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Marginal zone B cells mediate a CD4 T-cell–dependent extrafollicular antibody response following RBC transfusion in mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only